Global Retirement Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Global Retirement Partners’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-800	Closed	-$444	–	3367
2022 Q4	$444	Hold	800	–	–	﹤0.01%	2789
2022 Q3	$1K	Hold	800	–	–	﹤0.01%	2648
2022 Q2	$1K	Hold	800	–	–	﹤0.01%	2640
2022 Q1	$0	Buy	+800	New	+$956	﹤0.01%	2832
2021 Q4	–	Sell	-800	Closed	-$3K	–	1950
2021 Q3	$3K	Hold	800	–	–	﹤0.01%	1789
2021 Q2	$2K	Hold	800	–	–	﹤0.01%	1767
2021 Q1	$3K	Hold	800	–	–	﹤0.01%	1613
2020 Q4	$2K	Hold	800	–	–	﹤0.01%	1645
2020 Q3	$1K	Hold	800	–	–	﹤0.01%	1604
2020 Q2	$1K	Hold	800	–	–	﹤0.01%	1578
2020 Q1	$1K	Hold	800	–	–	﹤0.01%	1543
2019 Q4	$1K	Hold	800	–	–	﹤0.01%	1581
2019 Q3	$1K	Hold	800	–	–	﹤0.01%	1565
2019 Q2	$1K	Hold	800	–	–	﹤0.01%	1559
2019 Q1	$2K	Hold	800	–	–	﹤0.01%	1420
2018 Q4	$1K	Hold	800	–	–	﹤0.01%	1429
2018 Q3	$2K	Hold	800	–	–	﹤0.01%	1434
2018 Q2	$2K	Hold	800	–	–	﹤0.01%	1422
2018 Q1	$2K	Hold	800	–	–	﹤0.01%	1376
2017 Q4	$2K	Hold	800	–	–	﹤0.01%	1349
2017 Q3	$1K	Buy	+800	New	+$994	﹤0.01%	1191

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Retirement Partners's INFI Position: Q1 2023 in Review

Global Retirement Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 800 shares — an estimated $444 sold.

Global Retirement Partners first reported a position in INFI in Q3 2017 and held it in 21 quarters. The position peaked at $3K in Q3 2021. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

Global Retirement Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Global Retirement Partners sold 800 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $444.
Global Retirement Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2017 and held it in 21 quarters.
Global Retirement Partners's Infinity Pharmaceuticals, Inc. position peaked at $3K in Q3 2021.
53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Global Retirement Partners's 13F filing for Q1 2023, filed 8 May 2023.